Peter Schock, MD
Family Medicine · Bellevue, WANPI 1821160946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,287 and has fallen 78.9% since, to $272 in 2024. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$439
- AbbVie$312
- GSK$282
- AstraZeneca$222
- Novo Nordisk$217
- Lilly USA, LLC$199
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,31298%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 22 | $439 |
| AbbVie(2 entities) | 16 | $312 |
| GSK | 17 | $282 |
| AstraZeneca | 12 | $222 |
| Novo Nordisk | 13 | $217 |
| Lilly USA, LLC | 10 | $199 |
| Astellas Pharma US Inc | 5 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $140 |
| Kowa Pharmaceuticals America, Inc. | 8 | $135 |
| Antares Pharma, Inc. | 6 | $134 |
| Esperion Therapeutics, Inc. | 5 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Amarin Pharma, Inc. | 4 | $80 |
| Pfizer | 5 | $79 |
| Agile Therapeutics, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $72 |
| Boehringer Ingelheim | 3 | $64 |
| Johnson & Johnson | 3 | $58 |
| Sanofi Pasteur Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Novartis | 3 | $40 |
| Bausch Health US, LLC | 2 | $39 |
| Genentech USA, Inc. | 2 | $39 |
| Exact Sciences | 2 | $37 |
| Merck | 2 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Ironshore Pharmaceuticals Inc. | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Bayer | 1 | $25 |
| Abbott | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Halozyme Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
How this compares
$3,391 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 21 | $253 |
| Trazodone Hcl | 11 | $216 |
| Losartan Potassium | 14 | $148 |
| Hydrochlorothiazide | 12 | $29 |
| Meloxicam | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bellevue
- Andrew AppelbaumBellevue$16K
- Ho Sun SuhBellevue$12K
- Nathalie AcherBellevue$12K
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.